glp-1 shortage canada news today GLP-1 prescription trends through March 2026 CPHA: Canada Now Second-Largest GLP-1

In individuals with T2DM, the risk of fractures was assessed using a network meta-analysis and systematic review to determine the relationship between dipeptidyl peptidase-4 inhibitors (DPP-4i), GLP-1 RAs, and sodium-glucose cotransporter-2 inhibitors (SGLT-2i)

[PMID: 37940910]

Should I consider an SGLT2 inhibitor instead of or in addition to a GLP-1 medication, especially if I have heart failure or kidney disease

Navigating Treatment and Dietary Adjustments Managing Calories and Slower Progress on Mounjaro Weight loss progress can vary significantly from person to person, regardless of whether you choose a GLP-1 pill vs shots

Less common but involves distinct surgical planning

Clinicians should also be cautious in the case of T2D patients receiving drugs that inhibit the renin-angiotensin system